| LLY | Eli Lilly and Co | 20.62% |
| NVS | Novartis AG ADR | 10.62% |
| MRK | Merck & Co Inc | 9.85% |
| NVO | Novo Nordisk AS ADR | 5.38% |
| ABBV | AbbVie Inc | 4.60% |
| PFE | Pfizer Inc | 4.53% |
| BMY | Bristol-Myers Squibb Co | 4.51% |
| GSK | GSK PLC ADR | 4.42% |
| JNJ | Johnson & Johnson | 4.41% |
| AZN.L | AstraZeneca PLC | 4.34% |
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
VanEck Pharmaceutical ETF · Issued by VanEck
No recent news for PPH. The ingest cron pulls every 15 minutes during market hours.